Macquarie Downgrades Quest Diagnostics (DGX) to Neutral
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $234.40 -0.69%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Macquarie downgraded Quest Diagnostics (NYSE: DGX) from Outperform to Neutral with a price target cut from $62 to $52.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $57.28 yesterday.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $57.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades BSE Limited (BSE:IN) to Underperform
- JPMorgan Downgrades York Space Systems (YSS) to Neutral
- JPMorgan Upgrades PhysicsWallah Ltd (PWL:IN) to Overweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
